Form D · Other Health Care
Wave Life Sciences Pte Ltd
Singapore, U0 · CIK 0001631574
Offering snapshot reported Aug 28, 2015 · SEC filing
- Reported sold
- $66M Offering amount: $66M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 14, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2015 | Initial | $66,000,000 | No comparison | 19 | SEC filing |
| Feb 2, 2015 | Initial | $11,800,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.8M
- Finders' fees
- $0
- Form D file number
- 021-246665
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 39011 |
Source: Form D, filed Aug 28, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul B. Bolno, M.D. | Director, Executive |
| Peter Kolchinsky | Director |
| Koji Miura | Director |
| Tan Ping Ping | Executive |
| Ken Takanashi | Director |
| Masaharu Tanaka | Director |
| Gregory L. Verdine | Director |
| Takeshi Wada | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
8 Cross Street #10 00
Singapore, U0, 048424
Singapore, U0, 048424